Rotavirus Gastroenteritis

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2015-10-09
Clinical Trial Update: A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) [Phase 3]
A Phase 3 study evaluating immunogenicity and safety of a whole-cell pertussis–containing vaccine given with Rotarix or RotaTeq has been wit…
CLINICAL_TRIALS withdrawal · 2015-03-09
Clinical Trial Update: Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis
A clinical trial evaluating the Rotarix rotavirus vaccine in children aged 12 weeks to under 5 years hospitalized for severe gastroenteritis…